Cantor Fitzgerald analyst Charles Duncan reiterated a Buy rating on Cara Therapeutics (CARA – Research Report) today and set a
Tag: CARA
Stifel Nicolaus Keeps Their Buy Rating on Cara Therapeutics (CARA)
Stifel Nicolaus analyst Annabel Samimy reiterated a Buy rating on Cara Therapeutics (NASDAQ: CARA) yesterday and set a price target
Cara Therapeutics Gets a Buy Rating from Canaccord Genuity
Canaccord Genuity analyst Arlinda Lee maintained a Buy rating on Cara Therapeutics (NASDAQ: CARA) today and set a price target
Canaccord Genuity Keeps a Buy Rating on Cara Operations
In a new note to investors today, an analyst has provided a rating update for the Services sector company, Cara
Cara Therapeutics Receives a Buy from H.C. Wainwright
In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on Cara Therapeutics (NASDAQ: CARA), with
Needham Thinks Cara Therapeutics’ Stock is Going to Recover
Needham analyst Alan Carr maintained a Buy rating on Cara Therapeutics (NASDAQ: CARA) today and set a price target of
H.C. Wainwright Thinks Cara Therapeutics’ Stock is Going to Recover
In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on Cara Therapeutics (NASDAQ: CARA), with